CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −2,200 | $65.72 | $145K | 553,486 |
| 2026-06-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,429 | $66.72 | $95K | 552,057 |
| 2026-06-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −15,921 | $67.74 | $1.1M | 536,136 |
| 2026-06-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −450 | $68.27 | $31K | 535,686 |
| 2026-06-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −2,200 | $65.72 | $145K | 4,356,247 |
| 2026-06-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,429 | $66.72 | $95K | 4,354,818 |
| 2026-06-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −15,921 | $67.74 | $1.1M | 4,338,897 |
| 2026-06-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −450 | $68.27 | $31K | 4,338,447 |
| 2026-05-21 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −2,256 | $67.57 | $152K | 267,174 |
| 2026-05-21 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −6,725 | $68.30 | $459K | 260,449 |
| 2026-05-21 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,072 | $69.22 | $351K | 255,377 |
| 2026-05-21 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −11,250 | $70.48 | $793K | 244,127 |
| 2026-05-21 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −800 | $70.92 | $57K | 243,327 |
| 2026-05-18 | Trimarchi Thomas President and CFO | Sale 10b5-1 | −10,456 | $64.82 | $678K | 362,389 |
| 2026-05-18 | Trimarchi Thomas President and CFO | Sale 10b5-1 | −3,195 | $65.95 | $211K | 359,194 |
| 2026-05-16 | Trimarchi Thomas President and CFO | Shares withheld for taxes 10b5-1 | −22,781 | $66.13 | $1.5M | 372,845 |
| 2026-05-16 | Kumar Neil Chief Executive Officer | Option exercise | +33,544 | 267,995 | ||
| 2026-05-16 | Kumar Neil Chief Executive Officer | Option exercise | +19,599 | 287,594 | ||
| 2026-05-16 | Kumar Neil Chief Executive Officer | Option exercise | +11,553 | 299,147 | ||
| 2026-05-16 | Kumar Neil Chief Executive Officer | Option exercise | +6,519 | 305,666 |
Page 5 of 19 · 373 trades